Notice of Meeting; Interagency Autism Coordinating Committee, 10658-10659 [05-4171]
Download as PDF
<![CDATA[
10658
Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices
FOR FURTHER INFORMATION CONTACT:
Thomas E. Balbier, Jr., Executive
Director, Advisory Committee on Organ
Transplantation, at (301) 443–1896 or email Thom.Balbier@hrsa.hhs.gov or
Sherry Whipple, Public Health Analyst,
Division of Transplantation, at (301)
443–2764 or e-mail
Sherry.Whipple@hrsa.hhs.gov.
As
provided by 42 CFR 121.12 (64 FR
56661), the Secretary established the
Advisory Committee on Organ
Transplantation. The Committee is
governed by the Federal Advisory
Committee Act (5 U.S.C. Appendix 2),
which sets forth standards for the
formation and use of advisory
committees.
The ACOT advises the Secretary,
acting through the Administrator,
HRSA, on all aspects of organ
procurement, allocation, and
transplantation, and on other such
matters that the Secretary determines.
One of its principal functions shall be
to advise the Secretary on ways to
maximize Federal efforts to increase
living and deceased organ donation
nationally. Matters that may be
reviewed by the ACOT include the
following:
• Proposed enforceable OPTN
policies submitted for Secretarial
approval;
• Organ allocation policies of the
OPTN;
• The OPTN’s system of collecting,
disseminating and ensuring the validity,
accuracy, timeliness and usefulness of
data;
• The current state of knowledge
regarding transplantation; and
• Additional medical, public health,
ethical, legal, coverage and financing
issues and socioeconomic issues
relevant to transplantation.
The ACOT consists of up to 25
members, including the Chair. Members
and Chair shall be selected by the
Secretary from individuals
knowledgeable in such fields as organ
donation, health care public policy,
transplantation medicine and surgery,
critical care medicine and other medical
specialties involved in the identification
and referral of donors, non-physician
transplant professions, nursing,
epidemiology, immunology, law and
bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members. To the extent
practicable, Committee members should
represent the minority, gender and
geographic diversity of transplant
candidates, transplant recipients, organ
SUPPLEMENTARY INFORMATION:
VerDate jul<14>2003
19:07 Mar 03, 2005
Jkt 205001
donors and family members served by
the OPTN. In addition, the Director,
Centers for Disease Control and
Prevention; the Administrator, Centers
for Medicare and Medicaid Services; the
Commissioner, Food and Drug
Administration; and the Director,
National Institutes of Health (or the
designees of such officials) serve as nonvoting ex officio members.
Specifically, HRSA is requesting
nominations for up to 13 voting
members of the ACOT representing:
Thoracic transplant surgery, thoracic
transplant medicine (physicians), liver
transplant surgery, pediatrics, ethics,
organ procurement organizations,
transplant candidates/recipients, and
transplant/donor family members.
Nominees will be invited to serve a 4year term beginning approximately July
27, 2005, and ending July 26, 2009.
HHS will consider nominations of all
qualified individuals with a view to
ensuring that the Advisory Committee
includes the areas of subject matter
expertise noted above. Individuals may
nominate themselves or other
individuals, and professional
associations and organizations may
nominate one or more qualified persons
for membership on the ACOT.
Nominations shall state that the
nominee is willing to serve as a member
of the ACOT and appears to have no
conflict of interest that would preclude
the ACOT membership. Potential
candidates will be asked to provide
detailed information concerning
financial interests, consultancies,
research grants, and/or contracts that
might be affected by recommendations
of the Committee to permit evaluation of
possible sources of conflicts of interest.
A nomination package should include
the following information for each
nominee: (1) A letter of nomination
stating the name, affiliation, and contact
information for the nominee, the basis
for the nomination (i.e., what specific
attributes recommend him/her for
service in this capacity), and the
nominee’s field(s) of expertise; (2) a
biographical sketch of the nominee and
a copy of his/her curriculum vitae; and
(3) the name, return address, and
daytime telephone number at which the
nominator can be contacted.
The Department of Health and Human
Services has special interest in assuring
that women, minority groups, and the
physically disabled are adequately
represented on advisory committees;
and therefore, extends particular
encouragement to nominations for
appropriately qualified female,
minority, or disabled candidates.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Dated: February 24, 2005.
Elizabeth M. Duke,
Administrator.
[FR Doc. 05–4223 Filed 3–3–05; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting; Interagency Autism
Coordinating Committee
The National Institutes of Health
(NIH) hereby announces a meeting of
the Interagency Autism Coordinating
Committee to be held on May 16, 2005,
on the NIH campus in Bethesda,
Maryland.
The Children’s Health Act of 2000
(Pub. L. 106–310), Title I, Section 104,
mandated the establishment of an
Interagency Autism Coordinating
Committee (IACC) to coordinate autism
research and other efforts within the
Department of Health and Human
Services (HHS). In April 2001, the HHS
Secretary delegated the authority to
establish the IACC to the NIH. Within
the NIH, the National Institute of Mental
Health (NIMH) is the designated lead for
this activity.
The IACC meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting.
Name of Committee: Interagency Autism
Coordinating Committee.
Date: May 16, 2005.
Time: 9 a.m.–4:30 p.m.
Agenda: Discussion of autism activities
across Federal agencies.
Place: National Institutes of Health, 31
Center Drive, Building 31, Conference Room
10 (6th floor), Bethesda, Maryland 20892.
Contact Person: Ann Wagner, PhD,
Division of Services and Intervention
Research, NIMH, NIH, 6001 Executive
Boulevard, Room 7142, MSC 9633, Bethesda,
Maryland 20892, E-mail:
awagner@mail.nih.gov, Phone: 301–443–
4283.
Any member of the public interested in
presenting oral comments to the Committee
may notify Dr. Wagner, as listed above, at
least 5 days in advance of the meeting.
Interested individuals and representatives of
organizations may submit a letter of intent,
a brief description of the organization
represented, and a short description of the
oral presentation. Presentations may be
limited to 5 minutes; we request both printed
and electronic copies for the record. In
addition, any interested person may file
written comments with the Committee by
forwarding his or her statement to Dr.
E:\FR\FM\04MRN1.SGM
04MRN1
10659
Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices
Wagner, as listed above. The statement
should include the name, address, telephone
number, and, when applicable, the business
or professional affiliation of the interested
person.
Information about the meeting and online
registration forms are also available on the
NIMH homepage at https://
www.nimh.nih.gov/autismiacc/index.cfm.
Dated: February 23, 2005.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 05–4171 Filed 3–3–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration will publish
periodic summaries of proposed
projects. To request more information
on the proposed projects or to obtain a
copy of the information collection
plans, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Cross-Site Process
Evaluation of the Collaborative
Initiative To Help End Chronic
Homelessness—New
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA), Center for Mental Health
Services (CMHS) and Center for
Substance Abuse Treatment (CSAT) will
fund an evaluation of the Collaborative
Initiative to End Chronic Homelessness
(CHI). The CHI is assisting
unaccompanied homeless individuals
with a disabling condition who have
been continuously homeless for one
year or had at least four episodes of
homelessness in the past three years to
achieve permanent housing and make
use of supportive services. Within
SAMHSA, CMHS will be the lead
Center.
This evaluation will monitor and
describe the implementation and
progress of the 11 local projects of the
Initiative. A cross-site process
evaluation is needed to assure a high
level of accountability and to describe
and analyze the critical elements of the
projects that influence the clients, the
services, and the system outcomes,
using the same research methods for all
sites. SAMHSA will conduct an
evaluation by including a site-by-site
description of critical project elements
including qualitative descriptive
Number of
respondents
Instrument
information on the: project context,
target population, engagement activities,
housing, service delivery model,
staffing, service integration, systems
integration, and community planning.
Data collection will be conducted
over a 36-month period. At each project
site a series of measures will be used to
assess: (1) How chronically homeless
clients are assisted in obtaining
permanent housing and supportive
services, (2) how clients are maintained
in permanent housing and supportive
services, (3) how the project affects
client quality of life, (4) how the project
expands or enhances the existing
service system in the short-term and
long-term, (5) how the project extends
its reach to beyond the original number
of clients and project funding, (6) how
the project develops structures to
sustain itself after grant funding ends,
and (7) how the project influences local
policy related to homelessness.
Data collection instruments are semistructured and will be administered by
trained evaluation staff. Annual
interviews will be conducted with key
informants associated with the projects
through annual visits to project sites
and telephone interviews. Focus groups
with project consumers will be
conducted during annual visits. Onepage activity checklists will be required
every other month from a random
sample of project staff (staff may be
randomly selected more than once each
year). Project documentation from
project advisory and managerial groups
(e.g., meeting minutes) will be reviewed
for evidence of service system and
policy change.
The estimated annual response
burden to collect this information is as
follows:
Responses/
respondent
Burden/
response (hrs)
Annual burden
(hrs)
Project Coordinator Interview ............................................................
Team Lead Interview .........................................................................
Clinician Interview ..............................................................................
Case Manager Interview ....................................................................
Property Manager Interview ..............................................................
Advisory Board Member Interview ....................................................
Partner Agency/subcontractor Interview ............................................
Outside Stakeholder Interview ...........................................................
Consumer Focus Group ....................................................................
Activity Checklist ** ............................................................................
11
11
11
33
11
11
33
11
66
66
1
1
1
1
1
1
1
1
1
3
1.5
2
1
2
.5
1.2
1.2
.75
1.5
.5
17
22
11
66
6
13
40
8
99
99
Total Annual* ..............................................................................
264
............................
............................
380
* Sums and averages are rounded up to nearest integer.
** These respondents are selected from the same staff as the interviews above (project coordinator, team lead, clinician, case manager).
VerDate jul<14>2003
19:07 Mar 03, 2005
Jkt 205001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 70, Number 42 (Friday, March 4, 2005)]
[Notices]
[Pages 10658-10659]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4171]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting; Interagency Autism Coordinating Committee
The National Institutes of Health (NIH) hereby announces a meeting
of the Interagency Autism Coordinating Committee to be held on May 16,
2005, on the NIH campus in Bethesda, Maryland.
The Children's Health Act of 2000 (Pub. L. 106-310), Title I,
Section 104, mandated the establishment of an Interagency Autism
Coordinating Committee (IACC) to coordinate autism research and other
efforts within the Department of Health and Human Services (HHS). In
April 2001, the HHS Secretary delegated the authority to establish the
IACC to the NIH. Within the NIH, the National Institute of Mental
Health (NIMH) is the designated lead for this activity.
The IACC meeting will be open to the public, with attendance
limited to space available. Individuals who plan to attend and need
special assistance, such as sign language interpretation or other
reasonable accommodations, should notify the contact person listed
below in advance of the meeting.
Name of Committee: Interagency Autism Coordinating Committee.
Date: May 16, 2005.
Time: 9 a.m.-4:30 p.m.
Agenda: Discussion of autism activities across Federal agencies.
Place: National Institutes of Health, 31 Center Drive, Building
31, Conference Room 10 (6th floor), Bethesda, Maryland 20892.
Contact Person: Ann Wagner, PhD, Division of Services and
Intervention Research, NIMH, NIH, 6001 Executive Boulevard, Room
7142, MSC 9633, Bethesda, Maryland 20892, E-mail:
awagner@mail.nih.gov, Phone: 301-443-4283.
Any member of the public interested in presenting oral comments
to the Committee may notify Dr. Wagner, as listed above, at least 5
days in advance of the meeting. Interested individuals and
representatives of organizations may submit a letter of intent, a
brief description of the organization represented, and a short
description of the oral presentation. Presentations may be limited
to 5 minutes; we request both printed and electronic copies for the
record. In addition, any interested person may file written comments
with the Committee by forwarding his or her statement to Dr.
[[Page 10659]]
Wagner, as listed above. The statement should include the name,
address, telephone number, and, when applicable, the business or
professional affiliation of the interested person.
Information about the meeting and online registration forms are
also available on the NIMH homepage at https://www.nimh.nih.gov/
autismiacc/index.cfm.
Dated: February 23, 2005.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
[FR Doc. 05-4171 Filed 3-3-05; 8:45 am]
BILLING CODE 4140-01-P
